Evidence map›Paper›PMID 38212834›Full record

ArticleSubstance abuse treatment, prevention, and policy2024

Residential and inpatient treatment of substance use disorders in Sub-Saharan Africa: a scoping review.

Samuel Janson, Lily Nyenga, Haneefa Saleem, Larissa Jennings Mayo-Wilson, Stella E Mushy, Masunga K Iseselo, Jenna van Draanen, Joseph Tucker, Mecca McPherson, Donaldson F Conserve

Open access · goldAbstract readScoping Review
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Samuel JansonThe George Washington University Milken Institute School of Public Health, Washington, DC, USA. samjanson@gwu.edu.
Lily NyengaThe George Washington University Milken Institute School of Public Health, Washington, DC, USA.
Haneefa SaleemThe Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Larissa Jennings Mayo-WilsonThe University of North Carolina Gillings School of Public Health, Chapel Hill, North Carolina, USA.
Stella E MushyMuhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Masunga K IseseloMuhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Jenna van DraanenUniversity of Washington School of Public Health, Seattle, Washington, USA.
Joseph TuckerUniversity of North Carolina School of Medicine, Chapell Hill, North Carolina, USA.
Mecca McPhersonTemple University College of Public Health, Philadelphia, PA, USA.
Donaldson F ConserveThe George Washington University Milken Institute School of Public Health, Washington, DC, USA.
George Washington University · USMuhimbili University of Health and Allied Sciences · TZUniversity of North Carolina at Chapel Hill · USJohns Hopkins University · USMilken Institute · USTemple University · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith substance use rates increasing in Sub-Saharan Africa (SSA), an understanding of the accessibility and effectiveness of rehabilitative services for people who use alcohol and other drugs (AOD) is critical in the global efforts to diagnose and treat substance use disorders (SUD). This scoping review seeks to address the gaps in knowledge related to the types of research that have been conducted regarding inpatient or residential SUD treatment in SSA, the settings in which the research was conducted, and the study countries.

methodsA search of three databases, PubMED, Scopus, and African Index Medicus, was conducted for publications related to the treatment of SUD in inpatient or residential settings in SSA. Articles were screened at the title/abstract level and at full text by two reviewers. Articles eligible for inclusion were original research, conducted in SSA, published in English, included populations who received or were currently receiving treatment for SUD in inpatient or residential settings, or documented demand for SUD services.

resultsThis scoping review included 82 studies originating from 6 countries in SSA. Three themes emerged within the literature: access and demand for inpatient and residential SUD treatment, quality and outcomes of SUD treatment, and descriptions of the services offered and staffing of these facilities. Barriers to access include financial barriers, limited availability of services, and geographic concentration in cities. Women were shown to access residential and inpatient SUD treatment at lower rates than men, and certain racial groups face unique language and financial barriers in accessing services. Studies indicate mixed success of inpatient and residential SUD treatment in sustained SUD remission for patients.

conclusionThere are significant gaps in the literature, driven by a lack of longitudinal studies focused on patient outcomes following treatment and the use of a narrow definition of treatment success. Both structural and non-structural barriers, such as stigma and discrimination, are barriers to access. Further research is needed to evaluate approaches to mitigate these barriers and expand access to residential and inpatient SUD treatment.

Indexed as

Health Services AccessibilitySubstance-Related DisordersAfrica South of the SaharaFemaleHospitalizationHumansInpatientsMaleAddictionAnd alcohol rehabilitationDrugDrug and alcohol treatmentSub-Saharan AfricaSubstance use disorders

Identifiers

PMID38212834
PMCPMC10782522
OpenAlexW4390742734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.